Rubius Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2017 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rubius Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2017 to Q4 2022.
  • Rubius Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was -$1.13M, a 168% decline year-over-year.
  • Rubius Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $3.86M, a 40% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Interest Expense for 2022 was $3.86M, a 40% decline from 2021.
  • Rubius Therapeutics, Inc. annual Interest Expense for 2021 was $6.43M, a 53.7% increase from 2020.
  • Rubius Therapeutics, Inc. annual Interest Expense for 2020 was $4.19M, a 61.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $3.86M -$1.13M -$2.8M -168% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $6.66M $1.74M +$25K +1.46% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $6.63M $1.63M +$318K +24.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $6.32M $1.63M -$119K -6.81% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.43M $1.66M +$465K +38.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 $5.97M $1.71M +$537K +45.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.43M $1.31M +$484K +58.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.95M $1.75M +$763K +77.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4.19M $1.2M +$565K +89.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $3.62M $1.17M +$339K +40.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $3.28M $828K +$289K +53.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $2.99M $985K +$402K +69% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-20
Q4 2019 $2.59M $633K +$428K +209% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $2.16M $835K +$748K +860% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.41M $539K +$450K +506% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $964K $583K +$500K +602% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $464K $205K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $87K -$3K -3.33% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $89K +$17K +23.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $83K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q3 2017 $90K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $72K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.